BNP Paribas Financial Markets’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$361M Sell
5,947,732
-945,500
-14% -$55.1M 0.18% 107
2025
Q4
$372M Buy
6,893,232
+2,365,412
+52% +$114M 0.17% 102
2025
Q3
$204M Sell
4,527,820
-1,203,268
-21% -$56.2M 0.11% 171
2025
Q2
$265M Buy
5,731,088
+490,508
+9% +$24.1M 0.15% 116
2025
Q1
$320M Buy
5,240,580
+1,304,705
+33% +$76M 0.19% 110
2024
Q4
$223M Sell
3,935,875
-1,499,466
-28% -$83.8M 0.12% 147
2024
Q3
$281M Buy
5,435,341
+2,260,343
+71% +$106M 0.19% 104
2024
Q2
$132M Sell
3,174,998
-77,412
-2% -$3.46M 0.11% 180
2024
Q1
$176M Buy
3,252,410
+917,538
+39% +$46.7M 0.15% 138
2023
Q4
$120M Sell
2,334,872
-712,191
-23% -$37.4M 0.14% 166
2023
Q3
$177M Buy
3,047,063
+511,958
+20% +$31.4M 0.23% 83
2023
Q2
$162M Sell
2,535,105
-2,537,252
-50% -$170M 0.2% 92
2023
Q1
$352M Buy
5,072,357
+1,368,201
+37% +$96.5M 0.49% 30
2022
Q4
$267M Buy
3,704,156
+921,230
+33% +$69.5M 0.41% 35
2022
Q3
$198M Sell
2,782,926
-3,959,675
-59% -$287M 0.32% 52
2022
Q2
$519M Buy
6,742,601
+2,930,328
+77% +$223M 0.81% 9
2022
Q1
$278M Buy
3,812,273
+2,803,150
+278% +$188M 0.37% 42
2021
Q4
$62.9M Sell
1,009,123
-858,123
-46% -$50.3M 0.09% 242
2021
Q3
$110M Sell
1,867,246
-454,008
-20% -$29.9M 0.16% 142
2021
Q2
$155M Sell
2,321,254
-357,684
-13% -$23.3M 0.21% 107
2021
Q1
$169M Buy
2,678,938
+1,523,303
+132% +$94.8M 0.25% 87
2020
Q4
$71.7M Sell
1,155,635
-2,289,415
-66% -$141M 0.13% 154
2020
Q3
$208M Sell
3,445,050
-88,341
-3% -$5.32M 0.3% 63
2020
Q2
$208M Buy
3,533,391
+1,476,734
+72% +$88.3M 0.37% 52
2020
Q1
$115M Sell
2,056,657
-668,287
-25% -$40.8M 0.24% 86
2019
Q4
$175M Buy
2,724,944
+2,442,226
+864% +$140M 0.32% 56
2019
Q3
$14.3M Sell
282,718
-121,965
-30% -$5.73M 0.03% 624
2019
Q2
$18.4M Sell
404,683
-372,062
-48% -$17.3M 0.04% 481
2019
Q1
$37.1M Sell
776,745
-238,406
-23% -$11.9M 0.08% 264
2018
Q4
$52.8M Sell
1,015,151
-1,678,142
-62% -$90.2M 0.12% 188
2018
Q3
$167M Buy
2,693,293
+483,110
+22% +$28.7M 0.25% 77
2018
Q2
$122M Buy
2,210,183
+1,459,107
+194% +$78.8M 0.2% 98
2018
Q1
$47.5M Buy
751,076
+133,758
+22% +$8.6M 0.09% 212
2017
Q4
$37.8M Sell
617,318
-748,932
-55% -$46.8M 0.07% 272
2017
Q3
$87.1M Sell
1,366,250
-524,537
-28% -$30.6M 0.21% 89
2017
Q2
$105M Buy
1,890,787
+9,170
+0.5% +$499K 0.32% 67
2017
Q1
$102M Buy
1,881,617
+1,499,286
+392% +$82.2M 0.27% 76
2016
Q4
$22.3M Buy
382,331
+19,007
+5% +$1.04M 0.1% 170
2016
Q3
$19.6M Sell
363,324
-284,667
-44% -$18.3M 0.08% 182
2016
Q2
$47.7M Sell
647,991
-46,253
-7% -$3.27M 0.22% 71
2016
Q1
$44.3M Sell
694,244
-700,066
-50% -$44.1M 0.19% 95
2015
Q4
$95.9M Sell
1,394,310
-621,674
-31% -$41.1M 0.23% 75
2015
Q3
$119M Buy
2,015,984
+1,444,432
+253% +$91.6M 0.3% 53
2015
Q2
$38M Buy
571,552
+55,901
+11% +$3.68M 0.11% 113
2015
Q1
$33.3M Sell
515,651
-678,336
-57% -$42.5M 0.09% 134
2014
Q4
$70.5M Sell
1,193,987
-7,035
-0.6% -$397K 0.25% 74
2014
Q3
$61.5M Buy
1,201,022
+56,032
+5% +$2.8M 0.05% 165
2014
Q2
$55.5M Sell
1,144,990
-132,240
-10% -$6.52M 0.05% 152
2014
Q1
$64M Sell
1,277,230
-147,710
-10% -$7.86M 0.05% 149
2013
Q4
$75.7M Buy
1,424,940
+180,500
+15% +$9.19M 0.06% 140
2013
Q3
$57.6M Buy
1,244,440
+837,197
+206% +$36.7M 0.04% 185
2013
Q2
$18.2M Buy
+407,243
New +$17.7M 0.01% 246

Other funds holding BMY

BNP Paribas Financial Markets's BMY Position: Q1 2026 in Review

BNP Paribas Financial Markets reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, selling an estimated $55.1M and leaving 5,947,732 shares worth $361M. The position accounts for 0.18% of the portfolio, ranked #107.

BNP Paribas Financial Markets first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $519M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • BNP Paribas Financial Markets held 5,947,732 shares of Bristol-Myers Squibb worth $361M as of Q1 2026.
  • BNP Paribas Financial Markets sold 945,500 Bristol-Myers Squibb shares in Q1 2026, an estimated $55.1M.
  • Bristol-Myers Squibb made up 0.18% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #107 holding.
  • BNP Paribas Financial Markets first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Financial Markets's Bristol-Myers Squibb position peaked at $519M in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.